| Literature DB >> 32049009 |
Marie-Ming Aynaud1, Olivier Mirabeau1, Nadege Gruel2, Sandrine Grossetête1, Valentina Boeva3, Simon Durand1, Didier Surdez1, Olivier Saulnier1, Sakina Zaïdi1, Svetlana Gribkova4, Aziz Fouché5, Ulykbek Kairov6, Virginie Raynal1, Franck Tirode7, Thomas G P Grünewald2, Mylene Bohec8, Sylvain Baulande8, Isabelle Janoueix-Lerosey1, Jean-Philippe Vert9, Emmanuel Barillot10, Olivier Delattre11, Andrei Zinovyev12.
Abstract
EWSR1-FLI1, the chimeric oncogene specific for Ewing sarcoma (EwS), induces a cascade of signaling events leading to cell transformation. However, it remains elusive how genetically homogeneous EwS cells can drive the heterogeneity of transcriptional programs. Here, we combine independent component analysis of single-cell RNA sequencing data from diverse cell types and model systems with time-resolved mapping of EWSR1-FLI1 binding sites and of open chromatin regions to characterize dynamic cellular processes associated with EWSR1-FLI1 activity. We thus define an exquisitely specific and direct enhancer-driven EWSR1-FLI1 program. In EwS tumors, cell proliferation and strong oxidative phosphorylation metabolism are associated with a well-defined range of EWSR1-FLI1 activity. In contrast, a subpopulation of cells from below and above the intermediary EWSR1-FLI1 activity is characterized by increased hypoxia. Overall, our study reveals sources of intratumoral heterogeneity within EwS tumors.Entities:
Keywords: EWSR1-FLI1; Ewing sarcoma; Independent Component Analysis; intratumor heterogeneity; patient-derived xenografts; single-cell RNA-sequencing; time series; transcriptomics
Mesh:
Substances:
Year: 2020 PMID: 32049009 DOI: 10.1016/j.celrep.2020.01.049
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423